Eric P. Hanson
0000-0002-0318-4779
Publication & Citation Trends
Publications
0 total
RIPK1 signaling pathways: implications for autoimmune and neuroinflammatory diseases
Cited by 3
Semantic Scholar
B-143 Defining Proximity Limits for Semi-Annual Analytical Measurement Range Verification Studies
Cited by 0
Semantic Scholar
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype OA
Cited by 25
Semantic Scholar
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS OA
Cited by 82
Semantic Scholar
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model OA
Cited by 56
Semantic Scholar
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway OA
Cited by 38
Semantic Scholar
Distribution and functional consequences of somatic MAP2K1 mutations in affected skin associated with bone lesions in melorheostosis. OA
Cited by 3
Semantic Scholar
Key pathways in primary immune deficiencies
Cited by 0
Semantic Scholar
Research Topics
NF-κB Signaling Pathways
(12)
Immune Response and Inflammation
(11)
interferon and immune responses
(9)
Immune Cell Function and Interaction
(7)
Cytokine Signaling Pathways and Interactions
(7)
Affiliations
National Institutes of Health
Children's Hospital of Philadelphia
Howard Hughes Medical Institute
Eli Lilly (United States)
Pfizer (United States)